Inactive Instrument

Company Alzheon, Inc.

Equities

ALZH

US00168L1017

Biotechnology & Medical Research

Business Summary

Alzheon Inc is a United States-based clinical-stage biopharmaceutical company. The company is developing medicines for patients suffering from alzheimer's disease and other neurological and psychiatric disorders. The Company is focused on brain health, memory and aging and develops treatments for alzheimer's disease and other neurodegenerative disorders.

Number of employees: 6

Managers

Managers TitleAgeSince
Founder 59 01/13/01
Director of Finance/CFO 52 01/15/01
Chief Operating Officer - 13/21/13
Chief Tech/Sci/R&D Officer 63 01/15/01
Chief Tech/Sci/R&D Officer 64 -
General Counsel 48 -
Corporate Officer/Principal - 01/15/01
Corporate Officer/Principal - 01/15/01

Members of the board

Members of the board TitleAgeSince
Director/Board Member 62 08/20/08
Chairman 80 06/18/06
Founder 59 01/13/01
Director/Board Member 72 01/19/01
Director/Board Member 64 08/20/08

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 16,268,967 0 0 -

Company contact information

Alzheon, Inc.

111 Speen Street Suite 306

01701, Framingham

+508 861 7709

http://www.alzheon.com
address Alzheon, Inc.(ALZH)
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW